CLINICAL_TRIALS
trial_result
· 2011-05-03
Clinical Trial Update: Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue [Phase 2]
Summary
Phase 2 trial evaluating synthetic thyrotropin releasing hormone (TRH) for cancer-related fatigue was terminated; results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UConn Health | Conditions: Cancer-related Fatigue | Phase 2 | Status: TERMINATED | Results posted: 2011-05-03